Aurealis Therapeutics
PrivateLast Round
VC Round
Nov 13, 2024
Total Funding Raised
$15.77M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aurealis Therapeutics is a clinical-stage synthetic biology company that develops multi-target cell and gene therapies for chronic wounds, cancers, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aurealis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aurealis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 13, 2024 | ||||
| Series A | Mar 30, 2023 | ||||
| VC Round | Feb 12, 2019 | ||||
| Series A | Aug 25, 2017 |
Key People
Founding team and executive leadership
Aurealis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tesi | Series A |
| Lynx Financial | Series A |
| Finnvera | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 68% MoM.
- May 21, 2026
Monthly visitors increased 256% MoM, reaching 1.6K.
Aurealis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aurealis Therapeutics's valuation, stock price, and market status.